No-Reflow Phoenomenon by Intracoronary Thrombus in Acute Myocardial Infarction
- PMID: 26865998
- PMCID: PMC4742608
- DOI: 10.4068/cmj.2016.52.1.38
No-Reflow Phoenomenon by Intracoronary Thrombus in Acute Myocardial Infarction
Abstract
Recently, percutaneous coronary intervention has been the treatment of choice in most acute myocardial infarction cases. Although the results of percutaneous coronary interventions have ben good, the no-reflow phenomenon and distal embolization of intracoronary thrombus are still major problems even after successful interventions. In this article, we will briefly review the deleterious effects of no-reflow and distal embolization of intracoronary thrombus during percutaneous coronary interventions. The current trials focused on the prevention and treatment of the no-reflow phenomenon and intracoronary thrombus.
Keywords: Myocardial infarction; No-Reflow phenomenon; Percutaneous coronary intervention; Thrombus.
Conflict of interest statement
Similar articles
-
Randomized evaluation of intracoronary nitroprusside vs. adenosine after thrombus aspiration during primary percutaneous coronary intervention for the prevention of no-reflow in acute myocardial infarction: the REOPEN-AMI study protocol.J Cardiovasc Med (Hagerstown). 2009 Jul;10(7):585-92. doi: 10.2459/JCM.0b013e32832b3571. J Cardiovasc Med (Hagerstown). 2009. PMID: 19384242 Clinical Trial.
-
Is Atherothromboaspiration a Possible Solution for the Prevention of No-Reflow Phenomenon in Acute Coronary Syndromes? Single Centre Experience and Review of the Literature.Curr Vasc Pharmacol. 2019;17(2):164-179. doi: 10.2174/1570161116666180101150956. Curr Vasc Pharmacol. 2019. PMID: 29298651 Review.
-
Correlation between intracoronary thrombus components and coronary blood flow after percutaneous coronary intervention for acute myocardial infarction at different onset time.World J Clin Cases. 2019 Aug 6;7(15):2013-2021. doi: 10.12998/wjcc.v7.i15.2013. World J Clin Cases. 2019. PMID: 31423433 Free PMC article.
-
Pharmacological and physical prevention and treatment of no-reflow after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction.J Int Med Res. 2013 Jun;41(3):537-47. doi: 10.1177/0300060513479859. Epub 2013 Apr 29. J Int Med Res. 2013. Retraction in: J Int Med Res. 2014 Oct;42(5):1188. doi: 10.1177/0300060514545431. PMID: 23628920 Retracted. Review.
-
Combination therapy reduces the incidence of no-reflow after primary per-cutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction.J Geriatr Cardiol. 2015 Mar;12(2):135-42. doi: 10.11909/j.issn.1671-5411.2015.02.003. J Geriatr Cardiol. 2015. PMID: 25870616 Free PMC article.
Cited by
-
Predilation Ballooning in High Thrombus Laden STEMIs: An Independent Predictor of Slow Flow/No-Reflow in Patients Undergoing Emergent Percutaneous Coronary Revascularization.J Interv Cardiol. 2023 Jan 6;2023:4012361. doi: 10.1155/2023/4012361. eCollection 2023. J Interv Cardiol. 2023. PMID: 36712997 Free PMC article.
-
hsCRP and ET-1 expressions in patients with no-reflow phenomenon after Percutaneous Coronary Intervention.Pak J Med Sci. 2017 Jul-Aug;33(4):920-925. doi: 10.12669/pjms.334.13059. Pak J Med Sci. 2017. PMID: 29067066 Free PMC article.
-
Granulocyte colony-stimulating factor attenuates myocardial remodeling and ventricular arrhythmia susceptibility via the JAK2-STAT3 pathway in a rabbit model of coronary microembolization.BMC Cardiovasc Disord. 2020 Feb 17;20(1):85. doi: 10.1186/s12872-020-01385-5. BMC Cardiovasc Disord. 2020. PMID: 32066388 Free PMC article.
-
Role of smooth muscle cells in Cardiovascular Disease.Int J Biol Sci. 2020 Aug 21;16(14):2741-2751. doi: 10.7150/ijbs.49871. eCollection 2020. Int J Biol Sci. 2020. PMID: 33110393 Free PMC article. Review.
-
Stenting deferral in primary percutaneous coronary intervention: exploring benefits and suitable interval in heavy thrombus burden.Egypt Heart J. 2021 Sep 9;73(1):78. doi: 10.1186/s43044-021-00203-3. Egypt Heart J. 2021. PMID: 34499263 Free PMC article.
References
-
- Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction) Circulation. 2004;110:e82–e292. - PubMed
-
- Smith SC, Jr, Feldman TE, Hirshfeld JW, Jr, Jacobs AK, Kern MJ, King SB, 3rd, et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention) Circulation. 2006;113:e166–e286. - PubMed
-
- Michaels AD, Gibson CM, Barron HV. Microvascular dysfunction in acute myocardial infarction: focus on the roles of platelet and inflammatory mediators in the no-reflow phenomenon. Am J Cardiol. 2000;85:50B–60B. - PubMed
-
- Eeckhout E, Kern MJ. The coronary no-reflow phenomenon: a review of mechanisms and therapies. Eur Heart J. 2001;22:729–739. - PubMed
-
- Jaffe R, Charron T, Puley G, Dick A, Strauss BH. Microvascular obstruction and the no-reflow phenomenon after percutaneous coronary intervention. Circulation. 2008;117:3152–3156. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical